Comment on

• Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

  Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS, Morgan GJ. Rawstron AC, et al. Br J Haematol. 1997 Apr;97(1):46-55. doi: 10.1046/j.1365-2141.1997.72653.x. Br J Haematol. 1997. PMID: 9136941
• FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells.

  Davies FE, Rawstron AC, Pratt G, O'Connor S, Su'ut L, Blythe D, Fenton J, Claydon D, Child JA, Jack AS, Morgan GJ. Davies FE, et al. Br J Haematol. 1999 Jul;106(1):40-6. doi: 10.1046/j.1365-2141.1999.01506.x. Br J Haematol. 1999. PMID: 10444161
• Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation.

  Rottenburger C, Kiel K, Bösing T, Cremer FW, Moldenhauer G, Ho AD, Goldschmidt H, Moos M. Rottenburger C, et al. Br J Haematol. 1999 Aug;106(2):545-52. doi: 10.1046/j.1365-2141.1999.01548.x. Br J Haematol. 1999. PMID: 10460621
• The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients.

  Mitterer M, Oduncu F, Lanthaler AJ, Drexler E, Amaddii G, Fabris P, Emmerich B, Coser P, Straka C. Mitterer M, et al. Br J Haematol. 1999 Sep;106(3):737-43. doi: 10.1046/j.1365-2141.1999.01603.x. Br J Haematol. 1999. PMID: 10468867